Cell-based strategies for the treatment of kidney dysfunction: A review

Blood Purification

Volumn 34, Issue 2, 2012, Pages 117-123

  Pino, Christopher J ^a   Yevzlin, Alexander S ^d   Tumlin, James ^e   Humes, H David ^a,b,c  

^a Innovative BioTherapies Inc   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CytoPherx Inc   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Cell based therapy; End stage renal disease; Renal replacement; Renal tubule assist device; Stem cell; Tissue engineering

Indexed keywords

BIOMATERIAL; POLYSULFONE;

ACUTE KIDNEY FAILURE; AMMONIA FORMATION; CELL ADHESION; CELL THERAPY; CHRONIC KIDNEY DISEASE; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRYOPRESERVATION; ESCHERICHIA COLI; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION; GLUCONEOGENESIS; HEPARINIZATION; HORMONE RELEASE; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MESENCHYMAL STEM CELL; MORTALITY; NEPHRECTOMY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL TUBULE ASSIST DEVICE; RETROSPECTIVE STUDY; REVIEW; SELECTIVE CYTOPHERETIC DEVICE; SEPTIC SHOCK; STEM CELL; TISSUE ENGINEERING; UROLOGICAL EQUIPMENT;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 84867944039     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000341649     Document Type: Review

References (40)

1. Nigam S, Lieberthal W: Acute renal failure. 3. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol 2000; 279:F3-F11.
2. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996; 334: 1448-1460.
3. Lieberthal W, Nigam SK: Acute renal failure. 2. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278:F1-F12.
4. Lieberthal W, Nigam SK: Acute renal failure. 1. Relative importance of proximal vs distal tubular injury. Am J Physiol 1998; 275:F623-F631.
5. Breen D, Bihari D: Acute renal failure as a part of multiple organ failure: The slippery slope of critical illness. Kidney Int SUPPL 1998; 66:S25-S33.
6. US Renal Data System. USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
7. Humes HD: Bioartificial kidney for full renal replacement therapy. Semin Nephrol 2000; 20: 71-82.
8. Humes HD, MacKay SM, Funke AJ, Buffington DA: The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Am J Kidney Dis 1997; 30:S28-S31.
9. Lu CY, Hartono J, Senitko M, Chen J: The inflammatory response to ischemic acute kidney injury: A result of the 'right stuff' in the 'wrong place'? Curr Opin Nephrol Hypertens 2007; 16: 83-89.
10. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron 2002; 90: 133-138.
11. Humes HD: Cell therapy: Leveraging nature's therapeutic potential. J Am Soc Nephrol 2003; 14: 2211-2213.
12. Pino CJ, Humes HD: Stem cell technology for the treatment of acute and chronic renal failure. Transl Res 2010; 156: 161-168.
13. Humphreys BD, Bonventre JV: The contribution of adult stem cells to renal repair. Nephrol Ther 2007; 3: 3-10.
14. Bussolati B, Camussi G: Stem cells in acute kidney injury. Contrib Nephrol 2007; 156: 250-258.
15. Romagnani P: Toward the identification of a 'renopoietic system'? Stem Cells 2009; 27: 2247-2253.
16. Little MH, Bertram JF: Is there such a thing as a renal stem cell? J Am Soc Nephrol 2009; 20: 2112-2117.
17. MacKay SM, Funke AJ, Buffington DA, Humes HD: Tissue engineering of a bioartificial renal tubule. ASAIO J 1998; 44: 179-183.
18. Humes HD, Cieslinski DA: Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 1992; 201: 8-15.
19. Humes HD, Krauss JC, Cieslinski DA, Funke AJ: Tubulogenesis from isolated single cells of adult mammalian kidney: Clonal analysis with a recombinant retrovirus. Am J Physiol 1996; 271:F42-F49.
20. Humes HD, MacKay SM, Funke AJ, Buffington DA: Tissue engineering of a bioartificial renal tubule assist device: In vitro transport and metabolic characteristics. Kidney Int 1999; 55: 2502-2514.
21. Nikolovski J, Gulari E, Humes HD: Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 1999; 8: 351-364.
22. Humes HD, Fissell WH, Weitzel WF: The bioartificial kidney in the treatment of acute renal failure. Kidney Int SUPPL 2002; 80: 121-125.
23. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF: Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999; 17: 451-455.
24. Humes HD, et al: Cell therapy with a tissueengineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 2003; 31: 2421-2428.
25. Humes HD, et al: Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004; 66: 1578-1588.
26. Tumlin J, et al: Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19: 1034-1040.
27. Humes HD, Sobota JT, Ding F, Song JH: A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif 2010; 29: 183-190.
28. Fahy GM, Wowk B, Wu J: Cryopreservation of complex systems: The missing link in the regenerative medicine SUPPLy chain. Rejuvenation Res 2006; 9: 279-291.
29. Westover AJ, Buffington DA, Humes HD: Enhanced propagation of adult human renal epithelial progenitor cells to improve cell sourcing for tissue-engineered therapeutic devices for renal diseases. J Tissue Eng Regen Med 2012;6:589-597.
30. Buffington D, Pino C, Chen L, Westover A, Hageman G, Humes H: Bioartificial renal epithelial cell system (BRECS): A compact, cryopreservable extracorporeal renal replacement device. Cell Medicine 2012;4:33-43.
31. Rojas A, et al: Animal model of a wearable bioartificial kidney using peritoneal dialysis. ASAIO Annu Meet, Dallas, 2009.
32. Song J, et al: Uremic Animal Model of Bioartifical Renal Cell System (BRECS) Using Continuous Flow Peritoneal Dialysis-Based Extracorporeal Circuit. Renal Week 2009, San Diego, Calif., 2009.
33. Tintinger G, Steel HC, Anderson R: Taming the neutrophil: Calcium clearance and influx mechanisms as novel targets for pharmacological control. Clin Exp Immunol 2005; 141: 191-200.
34. Mandeville JT, Maxfield FR: Calcium and signal transduction in granulocytes. Curr Opin Hematol 1996; 3: 63-70.
35. Ding F, et al: A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. Plos One 2011; 6:e18584.
36. Pino CJ, Lou L, Smith PL, Ding F, Pagani FD, Buffington DA, Humes HD: A selective cytopheretic inhibitory device for use during cardiopulmonary bypass surgery. Perfusion 2012;27:311-319.
37. Ayub K, Hallett MB: Ca 2+ influx shutdown during neutrophil apoptosis: Importance and possible mechanism. Immunology 2004; 111: 8-12.
38. Ding F, et al: The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: A pilot study. ASAIO J 2011; 57: 426-432.
39. Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel K, DaSilva JR, Astor BC, Yevzlin AS, Humes HD: The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: A multi-center pilot study. Semin Dial 2012, DOI:10.1111/sdi.12032.
40. Mehta RL, et al: Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004; 66: 1613-1621.